Ads
related to: cirrhosis of the liver- Liver Transplants
Access Our Liver Transplant Guide.
Learn More About Liver Transplants.
- Liver Transplant Facts
Get a Free Liver Transplant Guide.
Learn More About Liver Transplants.
- Liver Transplants
Search results
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association...
Morningstar· 4 days agoGilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, June 5-8, 2024 in Milan, Italy. To drive ...
Symptoms of Fatty Liver Disease in Females: What You Should Know
Healthline· 3 days agoThe risk of females developing fatty liver disease rises significantly after menopause. Learn more...
AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF...
Morningstar· 3 days agoClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Akero ...
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks· 6 days agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in liver disease progression and reduced itching in primary biliary cholangitis study.
Health check information ‘could give risk score for multiple diseases’
Press Association News via AOL· 3 days agoThe illnesses included heart attack, heart failure, stroke, and atrial fibrillation – which causes...
Ozempic maker Novo Nordisk says it will study drug’s effects on alcohol consumption but isn’t...
7 News Boston· 6 days agoOver about three months, she told CNN in June, the medicine – which is approved for type 2 diabetes...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoSAN FRANCISCO, May 23, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. (NASDAQ: AKRO) investors who suffered substantial losses to submit their losses now. Class Period: Sep. 13, 2022 – Oct. 9, 2023Lead Plaintiff Deadline
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks via Yahoo Finance· 6 days agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 day agoAKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action ...
Hepatitis C: Thousands of people are undiagnosed—here's what you need to know about the virus
Medical Xpress· 5 days agoWhat is hepatitis C? Hepatitis C is a type of blood-borne virus that targets the liver, causing...
Ads
related to: cirrhosis of the liver